Valuation Novartis AG

Equities

Real-time Estimate Cboe Europe Other stock markets 05:17:55 2026-05-12 EDT			5-day change	1st Jan Change
113.99 ^CHF	+0.26%		+0.37%	+3.98%

05-11	Novo Nordisk to Sell Parkinson's Cell Therapy to Startup Cellular Intelligence	DJ
05-08	A lot of noise, little impact?

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	196,458	194,448	207,167	195,514	266,003	279,158	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	4.95%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	311,436	307,435	302,575
Change	-	-0.57%	7.71%	-2.61%	35.8%	7.44%	-1.28%	-1.58%
P/E ratio	8.2x	28.3x	14.1x	16.5x	19.2x	20.2x	17.3x	15.2x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	5.86x	5.61x	4.94x
PEG	-	-0.4x	0x	-1x	0.9x	40.24x	1x	1.1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	4.89x	4.61x	4.33x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.45x	5.07x	4.7x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	13.2x	12.1x	11x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	14.4x	13.2x	11.9x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	23x	18.9x	16.2x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	4.34%	5.28%	6.16%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.5	4.708	4.904
Rate of return	3.83%	3.87%	3.79%	3.94%	-	3.08%	3.22%	3.35%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.246	8.449	9.601
Distribution rate	31.4%	110%	53.5%	65.1%	-	62.1%	55.7%	51.1%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	57,141	60,592	64,405
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,513	25,373	27,612
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,568	23,363	25,323
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,149	15,685	17,564
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	32,279	28,277	23,417
Reference price ²	87.82	90.40	100.79	97.79	138.63	146.30	146.30	146.30
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,908,092	-	-
Announcement Date	2/2/22	2/1/23	1/31/24	1/31/25	2/4/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVARTIS AG	20.19x	5.45x	13.25x	3.08%	279B
ELI LILLY AND COMPANY	28.37x	10.33x	21.27x	0.7%	862B
JOHNSON & JOHNSON	23.66x	5.46x	14.85x	2.41%	533B
ABBVIE INC.	24.72x	6.13x	12.48x	3.38%	358B
ROCHE HOLDING AG	16.88x	4.23x	10.43x	3.14%	328B
ASTRAZENECA PLC	23.18x	4.81x	13.69x	1.8%	286B
MERCK & CO., INC.	49.65x	4.63x	17.32x	2.99%	275B
NOVO NORDISK A/S	13.62x	4.97x	10.19x	3.72%	210B
AMGEN INC.	21.19x	5.8x	10.07x	3.06%	178B
GILEAD SCIENCES, INC.	-48.25x	5.76x	32.18x	2.43%	166B
Average	17.32x	5.76x	15.57x	2.67%	347.46B
Weighted average by Cap.	21.87x	6.50x	16.05x	2.32%